ACTIVE

ReGenesys

Export PDF

Financial year 2021 · closed on 31/12/2021

Net result

-3,0 M €

-54.3% YoY

Revenue

1,0 M €

-12.6% YoY

Equity

-5,0 M €

-135.9% YoY

Workforce

13,2 ETP

-6.4% YoY

What does ReGenesys do?

ReGenesys is a Private limited company incorporated in 2005. Its main activity is: Research and experimental development on natural sciences and engineering. Its registered office is in Leuven. It employs on average 13,2 ETP workers (FTE).

Legal situation

● Normal situation

BCE/KBO no. / VAT

BE 0877.070.337

Incorporation

03/11/2005

Legal form

Private limited company

Registered office

Gaston Geenslaan 1
3001 Leuven · FlandreSee on map

Contributed capital

1 000 000,00 €

Latest accounts

31/12/2021

Average workforce

13,2 ETP

Activities (NACE)

72101Research and experimental development on natural sciences and engineering· main 72110Research and experimental development on biotechnology

Joint committees (2)

Signals

Healthy social debtsHigh revenue

View the BCE/KBO Public Search record →

Health score

Available with a Rovalta subscriptionTry for 7 days

Recommended credit limit

✦ Verdict · Analyst summary

Financials

Trend over 14 financial years

	2021		2018		2017		2016		2015		2014		2013		2012		2011		2010		2009		2008		2007		2006
Income statement
Revenue	1,0 M €	-12.6%	1,1 M €	+27.3%	902,4 k €	+22.9%	734,3 k €	-23.8%	964,2 k €	-23.0%	1,3 M €	+181%	446,0 k €	+241%	130,8 k €	+69.0%	77,4 k €		–		–		0,0 €		0,0 €		–
EBITDA	-2,6 M €	-78.9%	-1,5 M €	+1.8%	-1,5 M €	+2.1%	-1,5 M €	-21.1%	-1,3 M €	-4.0%	-1,2 M €	-14.4%	-1,1 M €	+37.2%	-1,7 M €	-1.2%	-1,7 M €	-147%	-670,9 k €	-849%	-70,7 k €	+53.4%	-151,6 k €	+25.2%	-202,6 k €	-7286%	-2,7 k €
Operating result	-2,8 M €	-44.7%	-2,0 M €	+9.4%	-2,2 M €	-4.8%	-2,1 M €	-12.9%	-1,8 M €	+3.9%	-1,9 M €	-9.1%	-1,7 M €	+19.5%	-2,2 M €	-1.9%	-2,1 M €	-96.8%	-1,1 M €	-317%	-258,1 k €	-8.2%	-238,5 k €	-17.4%	-203,1 k €	-7232%	-2,8 k €
Net result	-3,0 M €	-54.3%	-1,9 M €	+7.4%	-2,1 M €	-9.1%	-1,9 M €	-14.8%	-1,7 M €	-0.7%	-1,6 M €	-6.6%	-1,5 M €	+25.3%	-2,1 M €	-4.7%	-2,0 M €	-113%	-928,1 k €	-337%	-212,2 k €	+10.5%	-237,2 k €	-13.5%	-209,0 k €	-7460%	-2,8 k €
Balance sheet
Equity	-5,0 M €	-136%	-2,1 M €	-1385%	-143,7 k €	+89.5%	-1,4 M €	-511%	332,9 k €	+35.2%	246,3 k €	-28.3%	343,4 k €	+121%	-1,6 M €	-317%	-392,8 k €	-129%	1,3 M €	-28.5%	1,9 M €	+294%	475,0 k €	+346%	-193,2 k €	-5724%	3,4 k €
Total assets	637,3 k €	-67.0%	1,9 M €	-28.9%	2,7 M €	-11.9%	3,1 M €	+18.6%	2,6 M €	-5.4%	2,8 M €	-0.2%	2,8 M €	-0.5%	2,8 M €	+60.1%	1,7 M €	-12.2%	2,0 M €	-10.3%	2,2 M €	+216%	694,9 k €	+443%	128,0 k €	+1791%	6,8 k €
Cash	115,6 k €	-49.4%	228,4 k €	-69.4%	746,2 k €	+235%	222,9 k €	-63.6%	611,7 k €	+963%	57,6 k €	-40.3%	96,4 k €	-82.6%	554,1 k €	+575%	82,1 k €	-14.6%	96,0 k €	-85.0%	641,4 k €	+826%	69,2 k €	-25.0%	92,3 k €	+1390%	6,2 k €
Debts	5,6 M €	+40.6%	4,0 M €	+55.1%	2,6 M €	-38.2%	4,2 M €	+87.7%	2,2 M €	-9.7%	2,5 M €	+3.9%	2,4 M €	-46.3%	4,4 M €	+108%	2,1 M €	+236%	632,8 k €	+94.9%	324,7 k €	+47.6%	219,9 k €	-17.8%	267,7 k €	+7930%	3,3 k €
Other
Workforce	13,2 ETP	-6.4%	14,1 ETP	+5.2%	13,4 ETP	-1.5%	13,6 ETP	-3.5%	14,1 ETP	+7.6%	13,1 ETP	+6.5%	12,3 ETP	+24.2%	9,9 ETP	+11.2%	8,9 ETP	+64.8%	5,4 ETP	+170%	2,0 ETP	0.0%	2,0 ETP	+150%	0,8 ETP		–

Governance

Board of directors

Seen on filing of 31/12/2021 · 3 active · 11 ended

Active mandates

Dan Camardo

Director · since 01 juin 2022

Active

Ivor Macleod

Director · since 15 février 2021 · until 01 juin 2022

Active

William Otto Lehmann Jr.

Director · since 27 octobre 2005 · until 01 juin 2022

Active

Ended mandates

Ivor Macleod

Director · since 15 février 2021

Ended

CellAR

Manager · since 05 mars 2010 · 0810.901.192

Represented by Jozef PINXTEREN

Ended

CellAR

Manager · since 05 mars 2010 · until 01 novembre 2016 · 0810.901.192

Represented by Jozef Pinxteren

Ended

CellAR

Manager · since 05 mars 2010 · 0810.901.192

Represented by Jozef Pinxteren

Ended

At this address

Other companies at this address

Company	CBE no.
ALIGOS BELGIUM● Active	0702.969.886
Bio-Incubator Leuven● Active	0876.605.232
Community Building Arenberg● Active	1014.096.594
Creative Biolabs Belgium● Active	1028.942.544
DName-iT● Active	0506.754.823
Fisherman● Active	0804.287.079
Fishway● Active	0787.869.632
Formac Pharmaceuticals● Active	0892.914.395
IDA INTERNATIONAL● Active	1002.119.470
Lever Bio Belgium● Active	1039.455.958
Maatschap reMYND● Active	1019.655.090
miDiagnostics● Active	0641.984.602
Oxurion● Active	0881.620.924
PALEO● Active	0756.986.614
PARKEERGEBOUW● Active	1009.039.728
Pledge Therapeutics● Active	0726.743.301
Qmineral● Active	0837.633.897
Raya Therapeutic● Active	1003.128.171
ReGenesys EU● Active	0544.577.301
reMYND● Active	0476.910.101

Annual accounts

Full financial information

	2021	2020	2019	2018	2017	2016
Type of account	Full model	Full model	Full model	Full model	Full model	Full model
Start of the financial year	01/01/2021	01/01/2020	01/01/2019	01/01/2018	01/01/2017	01/01/2016
Closing of the financial year	31/12/2021	31/12/2020	31/12/2019	31/12/2018	31/12/2017	31/12/2016
Length of the financial year	12 months	12 months	12 months	12 months	12 months	12 months
Filing date	26/09/2023	11/08/2021	30/07/2020	30/07/2019	20/08/2018	28/07/2017
General meeting	11/08/2023	30/06/2021	30/06/2020	28/06/2019	29/06/2018	30/06/2017
Currency of the financial year	EUR	EUR	EUR	EUR	EUR	EUR
NBB quality label	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls

Ratios

Financial ratios

Looking for more information about this company?

Try for 7 days

Filings

Annual accounts filings

16 filings with the NBB

Model	Closing	General meeting	Filed	Language	Document
Full model	31/12/2021	11/08/2023	26/09/2023	Dutch	PDF
Full model	31/12/2020	30/06/2021	11/08/2021	Dutch	PDF
Full model	31/12/2019	30/06/2020	30/07/2020	Dutch	PDF
Full model	31/12/2018	28/06/2019	30/07/2019	Dutch	PDF
Full model	31/12/2017	29/06/2018	20/08/2018	Dutch	PDF
Full model	31/12/2016	30/06/2017	28/07/2017	Dutch	PDF
Full model	31/12/2015	30/09/2016	27/10/2016	Dutch	PDF
Full model	31/12/2014	21/08/2015	27/08/2015	Dutch	PDF
Full model	31/12/2013	30/06/2014	15/07/2014	Dutch	PDF
Full model	31/12/2012	17/06/2013	28/06/2013	Dutch	PDF
Full model	31/12/2011	07/09/2012	28/09/2012	Dutch	PDF
Full model	31/12/2010	30/06/2011	01/09/2011	Dutch	PDF
Full model	31/12/2009	30/06/2010	08/07/2010	Dutch	PDF
Full model	31/12/2008	30/06/2009	28/08/2009	Dutch	PDF
Full model	31/12/2007	30/06/2008	23/07/2008	Dutch	PDF
Full model	31/12/2006	15/06/2007	10/07/2007	Dutch	PDF

Estimate

Indicative valuation

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan

Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Governance

Board of directors

Seen on filing of 31/12/2021 · 3 active · 11 ended

Active mandates

Dan Camardo

Director · since 01 juin 2022

Active

Ivor Macleod

Director · since 15 février 2021 · until 01 juin 2022

Active

William Otto Lehmann Jr.

Director · since 27 octobre 2005 · until 01 juin 2022

Active

Ended mandates

Ivor Macleod

Director · since 15 février 2021

Ended

CellAR

Manager · since 05 mars 2010 · 0810.901.192

Represented by Jozef PINXTEREN

Ended

CellAR

Manager · since 05 mars 2010 · until 01 novembre 2016 · 0810.901.192

Represented by Jozef Pinxteren

Ended

CellAR

Manager · since 05 mars 2010 · 0810.901.192

Represented by Jozef Pinxteren

Ended

Shareholders

Ownership and network

Looking for more information about this company?

Try for 7 days

Belgian Official Gazette

Belgian Official Gazette publications

Mandates30/06/2022
ONTSLAGEN - BENOEMINGEN
PDF
Mandates10/05/2022
ONTSLAGEN - BENOEMINGEN
PDF
Mandates25/03/2021
ONTSLAGEN - BENOEMINGEN
PDF
Mandates04/03/2020
ONTSLAGEN - BENOEMINGEN
PDF
Other09/01/2020
WIJZIGING RECHTSVORM
PDF
Mandates21/11/2019
ONTSLAGEN - BENOEMINGEN
PDF
Other31/01/2018
DIVERSEN
PDF
Capital / shares17/01/2018
KAPITAAL - AANDELEN - STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, )
PDF

Source: Belgian Official Gazette

Competition

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

2021
Annual accounts 2021-3,0 M €↓
2018
Annual accounts 2018-1,9 M €↑
2017
Annual accounts 2017-2,1 M €↓
2016
Annual accounts 2016-1,9 M €↓
2015
Annual accounts 2015-1,7 M €↓
2014
Annual accounts 2014-1,6 M €↓
2013
Annual accounts 2013-1,5 M €↑
2012
Annual accounts 2012-2,1 M €↓
2011
Annual accounts 2011-2,0 M €↓
2010
Annual accounts 2010-928,1 k €↓
2009
Annual accounts 2009-212,2 k €↑
2008
Annual accounts 2008-237,2 k €↓
2007
Annual accounts 2007-209,0 k €↓
2006
Annual accounts 2006-2,8 k €
03/11/2005
IncorporationPrivate limited company

10/15	1 240 000	1 180 000	1 050 000
70	8 630 000	8 120 000	7 940 000
9904	412 000	388 000	301 000
17/49	2 970 000	3 140 000	3 380 000
9087	24,3	23,1	21,8

ReGenesys

Overview

What does ReGenesys do?

Trend over 14 financial years

Board of directors

Other companies at this address

Financials

Full financial information

Financial ratios

Annual accounts filings

Valuation

Indicative valuation

Directors & structure

Board of directors

Ownership and network

Publications

Belgian Official Gazette publications

Similar companies

Similar companies

Timeline